Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMYDA Pro 240
2011-005095-41Phase 3Active
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of clopidogrel in stable angina, acute coronary syndrome (ACS) and coronary arteriosclerosis (2 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoints: 30-day incidence of major adverse cardiac events after coronary angioplasty and Peri-procedural myocardial infarction. Started Dec 2011; status: active.
02
Drugs
clopidogrel
03
Conditions
stable anginaacute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-005095-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005095-41.